Sponsor:
TORL Biotherapeutics, LLC
Code:
NCT06690775
Conditions
Epithelial Ovarian Cancer
Primary Peritoneal
Fallopian Tube Cancer
Endometrioid Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TORL-1-23
TORL-1-23
TORL-1-23
Pegfilgrastim (drug)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by TORL Biotherapeutics, LLC on 2025-04-23.